Amphoteric ester sulfonates

US2018185801A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018185801-A1
Application numberUS-201815909653-A
CountryUS
Kind codeA1
Filing dateMar 1, 2018
Priority dateOct 20, 2014
Publication dateJul 5, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are a variety of amphoteric ester sulfonates, including 3-(N, N-dimethyl-cocoylpropylammonio-1-yl)-2-hydroxypropanesulfonate. These amphoteric ester sulfonates can be advantageously prepared in high yield and purity by a two-step chemoenzymatic process, and have excellent surfactant properties.

First claim

Opening claim text (preview).

We claim: 1 . A compound having the formula 1: wherein R is C 3 -C 23 hydrocarbyl; R 1 is C 3 -C 8 hydrocarbyl; R 2 and R 3 are each independently selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 dienyl, C 1 -C 6 trienyl, and C 3 -C 8 cycloalkyl; wherein at least two of R 1 , R 2 , and R 3 may be connected with the N + to form a heterocyclic ring; and R 4 is C 1 -C 8 hydrocarbyl substituted with a hydroxyl group. 2 . The compound according to claim 1 , wherein the hydrocarbyl group of R is substituted with one to five substituents selected from the group consisting of C 1 -C 6 alkoxy, C 1 -C 6 carboxyl, C 1 -C 15 aminocarbonyl, C 1 -C 15 amido, cyano, C 2 -C 6 alkoxycarbonyl, C 2 -C 6 alkanoyloxy, hydroxy, aryl, heteroaryl, thioether, C 2 -C 10 dialkylamino, C 3 -C 15 trialkylammonium, chlorine, and bromine. 3 . The compound according to claim 1 , wherein R is a C 3 -C 8 cycloalkyl group optionally substituted with one to five substituents selected from the group consisting of C 1 -C 6 alkoxy, C 1 -C 6 carboxyl, C 1 -C 15 aminocarbonyl, C 1 -C 15 amido, cyano, C 2 -C 6 alkoxycarbonyl, C 2 -C 6 alkanoyloxy, hydroxy, aryl, heteroaryl, thioether, C 2 -C 10 dialkylamino, C 3 -C 15 trialkylammonium, chlorine, and bromine. 4 . The compound according to claim 1 , wherein R 1 is selected from branched or straight-chain C 1 -C 8 alkylene, branched- or straight-chain C 2 -C 8 alkenylene, and substituted or unsubstituted C 3 -C 8 cycloalkylene. 5 . The compound according to claim 1 , wherein at least one of R 2 and R 3 is substituted with one to three substituents selected from the group consisting of C 1 -C 6 alkoxy, carboxyl, C 1 -C 15 aminocarbonyl, C 1 -C 15 amido, cyano, C 2 -C 6 alkoxycarbonyl, C 2 -C 6 alkanoyloxy, hydroxy, aryl, heteroaryl, thioether, C 2 -C 10 dialkylamino, C 3 -C 15 trialkylammonium, chlorine, and bromine. 6 . The compound according to claim 1 , wherein R is selected from the group consisting of C 5 -C 19 alkyl, C 5 -C 17 alkenyl, C 5 -C 17 dienyl, and C 3 -C 8 cycloalkyl; R 1 is selected from the group consisting of C 3 -C 8 alkylene, C 3 -C 8 alkenylene, and C 3 -C 8 cycloalkylene; R 2 and R 3 are each independently selected from the group consisting of C 1 -C 6 alkyl and C 1 -C 6 alkenyl; wherein R 1 and R 2 may be connected with the N + to form a C 3 -C 8 heterocyclic structure; and R 4 is C 1 -C 8 alkylene substituted with a hydroxyl group. 7 . The compound according to claim 1 , wherein RCO— is octanoyl, decanoyl, lauroyl, or a C 6 to C 20 acyl radical derived from coconut oil, hydrogenated coconut oil, hydrogenated and/or fractionated coconut oil fatty acids, palm kernel oil, hydrogenated palm kernel oil, or hydrogenated and/or fractionated palm kernel oil fatty acids; R 1 is 1,3-propylene or 1,3-butylene; R 2 and R 3 are methyl; and R 4 is 2-hydroxy-1,3-propylene. 8 . A compound having the formula 1: wherein R is C 3 -C 23 hydrocarbyl; R 1 is C 1 -C 8 hydrocarbyl; R 2 and R 3 are each independently selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 dienyl, C 1 -C 6 trienyl, and C 3 -C 8 cycloalkyl; wherein at least two of R 1 , R 2 , and R 3 are connected with the N + to form a heterocyclic ring; and R 4 is C 1 -C 8 hydrocarbyl. 9 . The compound according to claim 8 , wherein the heterocyclic ring is selected from the group consisting of pyrrolidinium, piperidinium, pyridinium, quinolinium, tetrahydroquinolinium, indolinium, octahydroindolinium, acridinium, octahydroacridinium, and tetradecahydroacridinium. 10 . The compound according to claim 8 , wherein RCO— is octanoyl, decanoyl, lauroyl, or a C 6 to C 20 acyl radical derived from coconut oil, hydrogenated coconut oil, hydrogenated and/or fractionated coconut oil fatty acids, palm kernel oil, hydrogenated palm kernel oil, or hydrogenated and/or fractionated palm kernel oil fatty acids; R 1 and R 2 are connected with the N + to form a 3-piperidininum, a 4-piperidinium, a 3-piperidiniummethyl, a 4-piperidiniummethyl, a 3-pyridinum, a 4-pyridinium, a 3-pyridiniummethyl, or a 4-pyridiniummethyl group; R 3 is methyl; and R 4 is ethylene, 1,3-propylene, 1,4-butylene, or 2-hydroxy-1,3-propylene. 11 . A process for preparing a compound having the formula 1: wherein R is C 3 -C 23 hydrocarbyl; R 1 is C 1 -C 8 hydrocarbyl; R 2 and R 3 are each independently selected from the group consisting of C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 dienyl, C 1 -C 6 trienyl, and C 3 -C 8 cycloalkyl; wherein at least two of R 1 , R 2 , and R 3 may be connected with the N + to form a heterocyclic ring; and R 4 is C 1 -C 8 hydrocarbyl, the process comprising: (a) contacting an acid or ester of formula 2 with a dialkylamino-alcohol of formula 3: in the presence of an enzyme at conditions effective to form an intermediate of formula 4: wherein R, R 1 , R 2 , and R 3 are as defined above and R 7 is hydrogen or C 1 -C 6 alkyl; and (b) contacting the intermediate of formula 4 with a sulfonate alkylating agent at conditions effective to form the compound of formula 1. 12 . The process according to claim 11 , wherein the enzyme is a lipase from Pseudomonas sp or Candida antarctica. 13 . The process according to claim 11 , wherein step (a) is carried out at a temperature of 50 to 70° C. and a pressure of 10 Torr (1,333 Pa) to ambient pressure, and wherein step (b) is carried out at a temperature of 50 to 125° C. 14 . The process according to claim 11 , which further comprises removing water or alcohol by-product from the reaction mixture during step (a). 15 . The process according to claim 11 , wherein step (b) is carried out in the presence of a base selected from the group consisting of metal hydroxides, metal carbonates, and metal bicarbonates; and wherein step (b) is carried out in the presence of a solvent selected from the group consisting of water, C 2 -C 5 alcohols, ether-alcohols, and mixtures thereof. 16 . The process according to claim 11 , wherein the sulfonate alkylating agent is selected from the group consisting of 1,3-propanesultone, 1,4-butanesultone, sodium 2-chloroethanesulfonate, and sodium 3-chloro-2-hydroxypropanesulfonate. 17 . The process according to claim 11 , wherein R is selected from the group consisting of C 5 -C 19 alkyl, C 5 -C 17 alkenyl, C 5 -C 17 dienyl, and C 3 -C 8 cycloalkyl; R 1 is selected from the group consisting of C 1 -C 8 alkylene, C 2 -C 8 alkenylene, and C 3 -C 8 cycloalkylene; R 2 and R 3 are each independently selected from the group consisting of C 1 -C 6 alkyl and C 1 -C 6 alkenyl; wherein R 1 and R 2 may be connected with the N + to form a C 3 -C 8 heterocyclic structure; and R 4 is C 1 -C 8 alkylene. 18 . The process according to claim 11 , wherein at least two of R 1 , R 2 , and R 3 are connected with the N + to form a heterocyclic ring

Assignees

Inventors

Classifications

  • having a hydrogen atom as the second substituent in position 4 · CPC title

  • C07C309/14Primary

    containing amino groups bound to the carbon skeleton · CPC title

  • by oxygen atoms · CPC title

  • Sulfobetaines {; Sulfitobetaines} · CPC title

  • Amines; Imines · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018185801A1 cover?
Disclosed are a variety of amphoteric ester sulfonates, including 3-(N, N-dimethyl-cocoylpropylammonio-1-yl)-2-hydroxypropanesulfonate. These amphoteric ester sulfonates can be advantageously prepared in high yield and purity by a two-step chemoenzymatic process, and have excellent surfactant properties.
Who is the assignee on this patent?
Eastman Chem Co
What technology area does this patent fall under?
Primary CPC classification C07C309/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jul 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).